June 18, 2020 / 11:28 AM / 25 days ago

BRIEF-Emergent Biosolutions To Invest $75 Mln In Canton Site And Expand Viral Vector And Gene Therapy Capability

June 18 (Reuters) - Emergent BioSolutions Inc:

* EMERGENT BIOSOLUTIONS TO INVEST $75 MILLION IN CANTON SITE AND EXPAND VIRAL VECTOR AND GENE THERAPY CAPABILITY

* EMERGENT BIOSOLUTIONS INC - ADVANCED THERAPY CDMO DRUG SUBSTANCE MANUFACTURING SERVICES EXPECTED TO BE AVAILABLE BEGINNING IN 2023 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below